Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Capital Expenditures (2022 - 2023)

Vycor Medical (VYCO) has disclosed Capital Expenditures for 6 consecutive years, with $5904.0 as the latest value for Q4 2023.

  • Quarterly Capital Expenditures rose 1933.54% to $5904.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$1379.0 through Dec 2023, down 149.6% year-over-year, with the annual reading at $5224.0 for FY2025, 2.65% down from the prior year.
  • Capital Expenditures for Q4 2023 was $5904.0 at Vycor Medical, up from -$322.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $5904.0 in Q4 2023, with the low at -$6865.0 in Q2 2022.